维普中文期刊产品整合服务
79篇 您的检索式:作者名="Wittrant"
    题名 作者 年代 出处 被引量
1Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities显示文摘Y Wittrant S Theoleyre S Couillaud C Dunstan D Heymann F Rédini 2003Experimental Cell Research2003,,2:2
2Prebiotic effects: metabolic and health benefits显示文摘Roberfroid M Gibson G R Hoyles L McCartney A L Rastall R Rowland I Wolvers D Watztl B Szajewska H Stahl B Guarner F Respondek F Whelan K Coxam V Davieco M Laotoing L Wittrant Y Delzenne N Cani P Neyrinek A Meheust A 2010British Journal of Nutrition2010,104,2:1
3The molecular triad OPG/RANK/RANKL:involvement in the orchestration of pathophysiological bone remodeling显示文摘Theoleyre S Wittrant Y Tat SK 0,,06:1
4The molecular triad OPG/RANK/RANKL: involvement in the or- chestration of pathophysiological bone remodeling 显示文摘Theoleyre S Wittrant Y Tat S K 2004Cytokine Growth Factor Rev2004,15,6:1
5Cellular activity and signaling induced by ostoprotegerin in os- teoclasts:involvement of receptor activator of nuclear factor κB ligand and MAPK 显示文摘Theoleyre S Wittrant Y Couillaud S 2004Biochimica et Bio- physica Acta2004,1644,1:1
6Osteoprotegerin differentially regulates protease expression in osteoclast cultures 显示文摘Wittrant Y Couillaud S Theoleyre S 2002Biochem Biophys Res Commun2002,293,1:1
7Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-κB ligand and osteoprotegerin biological activities显示文摘Wittrant Y Theoleyre S Couillaud S 2004Exp Cell Res2004,293,4:1
8The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling显示文摘THEOLEYRE S WITTRANT Y TAT S K 2004Cytokine Growth Fact or Rev2004,15,:1
9High d (+) glucose con-centration inhibits RANKL -induced osteoclastogenesis 显示文摘Wittrant Y Gorin Y Woodruff K 2008Bone2008,42,6:1
10Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma:Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption显示文摘Lamoureux F Richard P Wittrant Y 2007Cancer Res2007,67,:1
11Regulation of osteoclast protease expression by RANKL显示文摘Y Wittrant S Theoleyre S Couillaud C Dunstan D Heymann F Rédini 2003Biochemical and Biophysical Research Communications2003,,3:1
12High d (+)glucose concentration inhibits RANKL-induced osteoclastogenesis显示文摘Y. Wittrant Y. Gorin K. Woodruff D. Horn H.E. Abboud S. Mohan S.L. Abboud-Werner 2008Bone2008,,6:1
13The molecular triad OPG/RANK/ RANKL:involvement in the orchestration of pathophysiological bone re- modeling 显示文摘Theoleyre S Wittrant Y Tat SK 2004Cytokine Growth Factor Rev2004,15,7:1
14Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma:blockade of the vicious cycle between tumor cell proliferation and bone resorption显示文摘Lamoureux F Richard P Wittrant Y 2007Cancer Res2007,67,8:1
15The molecular triad OPG/RANK/RANKL:involvement in the orchestration of pathophysiological bone remodeling显示文摘Theoleyre S Wittrant Y Tat SK 2004Cytokine Growth Factor Rev2004,15,6:1
16Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma:blockade of the vicious cycle between tumor cell proliferation and bone resorption显示文摘LAMOUREUX F RICHARD P WITTRANT Y 2007Cancer Res2007,67,15:1
17RANKL/RANK/ OPG:new therapeutic targets in bone tumours and associated osteolysis显示文摘Wittrant Y Theoleyre S Chipoy C 2004Biochimicaet Biophysica Acta2004,1704,2:1
18Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption显示文摘Lamoureux F Richard P Wittrant Y 2007Cancer Res2007,67,15:1
19Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF -KB ligand and osteoprotegerin biological activities显示文摘Wittrant Y Theoleyre S Couillaud S 2004Exp Cell Res2004,293,2:1
20Regulation of osteoclast protease expression by RANKL显示文摘 Theoleyre S Couillaud S 2003Biochem Biophysic Res Commun2003,310,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费